Effectiveness of first-line treatment with recombinant interleukin-1 receptor antagonist in steroid-naive patients with new-onset systemic juvenile idiopathic arthritis: results of a prospective cohort study.

S.J. Vastert, W. de Jager, B.J. Noordman, D. Holzinger, W. Kuis, A.B.J. Prakken, N.M. Wulffraat

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1034-1043
Number of pages10
JournalArthritis & Rheumatology
Volume66
Issue number4
DOIs
Publication statusPublished - 2014

Cite this